Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) EBIT (2016 - 2025)

Historic EBIT for Neuroone Medical Technologies (NMTC) over the last 14 years, with Q4 2025 value amounting to -$1.7 million.

  • Neuroone Medical Technologies' EBIT fell 19977.21% to -$1.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$7.6 million, marking a year-over-year decrease of 1266.61%. This contributed to the annual value of -$4.2 million for FY2025, which is 6444.52% up from last year.
  • According to the latest figures from Q4 2025, Neuroone Medical Technologies' EBIT is -$1.7 million, which was down 19977.21% from -$1.4 million recorded in Q3 2025.
  • Neuroone Medical Technologies' EBIT's 5-year high stood at $1.7 million during Q4 2024, with a 5-year trough of -$3.5 million in Q2 2023.
  • In the last 5 years, Neuroone Medical Technologies' EBIT had a median value of -$2.8 million in 2022 and averaged -$2.4 million.
  • In the last 5 years, Neuroone Medical Technologies' EBIT skyrocketed by 15047.1% in 2024 and then crashed by 19977.21% in 2025.
  • Over the past 5 years, Neuroone Medical Technologies' EBIT (Quarter) stood at -$2.8 million in 2021, then skyrocketed by 36.48% to -$1.8 million in 2022, then plummeted by 90.01% to -$3.4 million in 2023, then surged by 150.47% to $1.7 million in 2024, then crashed by 199.77% to -$1.7 million in 2025.
  • Its last three reported values are -$1.7 million in Q4 2025, -$1.4 million for Q3 2025, and -$1.9 million during Q2 2025.